Cancer Therapy-induced Cardiotoxicity

Aaron L Sverdlov, MBBS, PhD, FRACP, FCSANZ, FESC, FHFA, FACC

Heart Foundation Future Leader Fellow
A/Prof & Director of Heart Failure
Co-Director, Cancer and the Heart Program
University of Newcastle, HMRI, HNELHD, John Hunter Hospital, Calvary Mater Newcastle

Jump to:
Please wait...
aaronsverdlov
Aaron Sverdlov is a heart failure cardiologist and a clinician-scientist. He completed his medical degree, cardiology training and PhD in Adelaide, and then undertook Postdoctoral Fellowship in Heart Failure at the Boston University. He is a past NHMRC CJ Martin Fellow, AHA postdoctoral Fellow and is a current Heart Foundation of Australia Future Leader Fellow. Aaron has had over 50 peer reviewed publications, and has received over $3M AUD in competitive research grant funding in Australia and overseas. He is an Associate Professor and Director of Heart Failure at the University of Newcastle and Clinical Lead for Heart Failure Services for Hunter New England LHD. He is a Co-director of Cardiometabolic and Vascular research groups at the University of Newcastle. Aaron has established and leads the bench-to-bedside “Cancer and the Heart” research and clinical program at the John Hunter and Calvary Mater Newcastle Hospitals.
Scroll to top

Enter the serial number on your certificate to access the GET Weekend archive of the various lectures!

For medical enquiries please contact 1800 671 203 (ph.)
or medinfo.phauno@novartis.com (email)

Novartis Pharmaceuticals Australia Pty Limited. ABN: 18 004 244 160
54 Waterloo Road, Macquarie Park NSW 2113. AU-9334 May 2019